MiniMed Group (NASDAQ: MMED) says General Counsel Courtney Nelson Wills will step down
Rhea-AI Filing Summary
MiniMed Group, Inc. disclosed that Courtney Nelson Wills, Senior Vice President, General Counsel and Corporate Secretary, has decided to resign from her position. She notified the company on July 30, 2026, and her resignation will be effective September 25, 2026 following an 8‑week transition period.
The company states that Ms. Nelson Wills is leaving for personal reasons, having accepted a role outside the medical device industry, and that her departure is not due to any disagreement with MiniMed. MiniMed is conducting a search for a successor and emphasizes its commitment to maintaining strong legal, governance, and compliance oversight during the transition. The disclosure also includes standard forward‑looking statements language referencing risks and uncertainties described in its SEC reports.
Positive
- None.
Negative
- Senior legal officer resignation: MiniMed’s Senior Vice President, General Counsel and Corporate Secretary, Courtney Nelson Wills, will resign effective September 25, 2026, creating a leadership transition in the company’s legal and governance function.
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Notification date: July 30, 2026
Effective resignation date: September 25, 2026
Transition period: 8-week transition period
3 metrics
Notification date
July 30, 2026
Date Courtney Nelson Wills informed MiniMed of her decision to resign
Effective resignation date
September 25, 2026
Date her resignation as Senior Vice President, General Counsel and Corporate Secretary becomes effective
Transition period
8-week transition period
Length of transition period before her resignation becomes effective
Key Terms
emerging growth company, forward-looking statements, Private Securities Litigation Reform Act of 1995, corporate governance
4 terms
emerging growth company regulatory
"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ... Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
forward-looking statements regulatory
"This filing contains forward-looking statements within the meaning of the Private Securities"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Private Securities Litigation Reform Act of 1995 regulatory
"forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995"
corporate governance regulatory
"Title: Senior Counsel, Securities & Corporate Governance, Assistant Corporate Secretary"
Corporate governance is the system of rules, roles and oversight that determines how a company is directed and controlled, including the responsibilities of its board, executives and shareholders. Like the steering wheel and map for a car trip, it shapes decisions, sets checks on power and defines who can hold leaders accountable; strong governance reduces risk, builds trust and helps investors judge whether a company is likely to protect capital and deliver reliable returns.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What leadership change did MiniMed Group (MMED) announce on July 30, 2026?
MiniMed Group reported that Courtney Nelson Wills, its Senior Vice President, General Counsel and Corporate Secretary, will resign effective September 25, 2026. She informed the company on July 30, 2026 and will assist during an 8‑week transition period.
When is MiniMed Group’s (MMED) General Counsel resignation effective?
The resignation of Courtney Nelson Wills as Senior Vice President, General Counsel and Corporate Secretary becomes effective on September 25, 2026. She will remain with MiniMed for an 8‑week transition to help facilitate a smooth handover of her responsibilities.
Why is MiniMed Group’s (MMED) General Counsel Courtney Nelson Wills leaving?
MiniMed states that Courtney Nelson Wills is departing for personal reasons after accepting a role outside the medical device space. The company explicitly notes that her departure is not the result of any disagreement with MiniMed regarding its operations, policies, or practices.
How is MiniMed Group (MMED) handling the transition after its General Counsel resigns?
MiniMed is conducting a search for a successor to Courtney Nelson Wills and highlights her assistance in ensuring a seamless leadership transition. The company states it remains committed to strong legal, governance, and compliance oversight throughout this period.
Does MiniMed Group (MMED) link the General Counsel’s resignation to any dispute?
No. MiniMed specifically states that Ms. Nelson Wills’s departure is not the result of any disagreement with the company. Her resignation is attributed to personal reasons, including accepting a position outside the medical device industry, according to the company’s disclosure.